Protective effect of decorin on acute ischaemia-reperfusion injury in the rat kidney by Alan, Cabir et al.
Protective effect of decorin on acute 
ischaemia-reperfusion injury in the rat kidney
Cabir Alan
1, Hasan Kocoglu
2, Ramazan AltIntas
3, Bülent AlIcI
3, Ahmet Resit Ersay
1
Abstract
Introduction: Transforming growth factor-β1 (TGF-β1) has a crucial role in collagen
synthesis and fibrosis. TGF-β1 can be antagonized and/or reduced by the action
of certain agents. We propose to identify the role of decorin in treatment of
tubular and interstitial fibrosis and in the inhibition of TGF-β1 in an acute
ischaemic kidney.
Material and methods: We grouped 34 female Sprague Dawley type rats into 
3 groups as 9 sham, 9 ischaemia-reperfusion (I/R) and 16 I/R + decorin
respectively. The rats in the I/R + decorin group had decorin administered
intraperitoneally at the dose of 0.1 mg/kg for 9 days after reperfusion. After 
9 days, all the rats in the 3 groups were unilaterally nephrectomized. The TGF-β1
level was measured immunohistochemically in the nephrectomized material.
Results: The TGF-β1 level was lower in the I/R + decorin group. Evaluation of
apoptotic activity level by caspase staining showed a statistically significant
difference between the 3 groups. The number of caspase stained cells was lower
in the I/R + decorin group. The amount of collagen in interstitial tissue was
higher in the I/R group than in the I/R + decorin group, but this difference was
not statistically significant.
Conclusions: We found that the TGF-β1 level – the so-called initiator of fibrotic
activity – and apoptotic activity were low in the I/R + decorin group. Additional
studies must be performed to understand the role of decorin in inhibition of
TGF-β1 and to assess decorin’s routine use in acute renal ischaemia.
Key words: transforming growth factor-β1, decorin, glomerulosclerosis.
Introduction
Renal ischaemia is observed in conditions such as renal transplantation,
partial nephrectomy, cardiopulmonary bypass, sepsis, various urological
interventions and hydronephrosis. Ischaemia reperfusion damage may give
rise to stimulation of tumour necrosis factors (TNF), cytokines such as
interferon and TGF-β1 (transforming growth factor-β1) in kidney tissue [1].
TGF-β1 stimulates synthesis of an extracellular matrix in the mesangium
and between epithelial cells. TGF-β1 is a cytokine that plays a key role in
pathogenesis of fibrosis. According to the authors TGF-β1 is the most
important growth factor in pathogenesis of glomerulosclerosis [2, 3]. 
TGF-β1 is excessively found in thrombocytes. When tissue damage occurs,
it is excreted by degranulation and provides chemoattraction of
inflammatory cells and thrombocytes which are responsible for fibrosis. 
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It is postulated that TGF-β1 activation is initiated
by mechanical changes due to trauma and/or an
inflammatory process [4-6]. Moreover, hypoxic
media caused by vascular insufficiency may
enhance TGF-β1 synthesis. Some studies have
found that the crucial role of TGF-β1 in collagen
synthesis and fibrosis may be antagonized and/or
reduced by the action of certain agents. Among
these agents decorin has an important role because
it is naturally found in the body and has a higher
specificity [7, 8]. Decorin, like other biglycans,
fibromodulin and lumican, is found excessively
around the tubulus. Decorin neutralizes TGF-β1
activity, and is used in treatment of TGF-β1 growth
factor-producing tumours and diseases presenting
with fibrotic reactions [9-13]. According to the
literature mentioned above it was hypothesized
that decorin may be helpful in the treatment of
renal ischaemia-related events.
In our study we aim to identify the role of the
proteoglycan decorin in the treatment of tubular
and interstitial fibrosis and the association between
TGF-β1 and renal fibrosis and apoptosis in an acute
ischaemic kidney.
Material and methods
We grouped 34 female Sprague Dawley rats,
mean weight 200 g (186-220 g), into 3 groups as 
9 sham, 9 ischaemia-reperfusion (I/R) and 16 I/R +
decorin. All subjects were kept in boxes at
a temperature of 22 ±2°C. Four rats inhabited each
box.
All the rats were taken to the experiment table
and sedated with ketamine 100 mg/kg (Ketalar,
EczacIbașI, Turkey). During the experiment body
temperature was kept at 36-38°C by a heated table
controlled by a rectal thermometer. The anterior
abdominal wall was incised on the median line. The
left renal pedicle was found and blood circulation
stopped via an atraumatic vascular clamp. After 
60 min of ischaemia the clamps were released and
blood circulation was allowed. After recirculation
a colour change was observed in the kidney for 
2 min. The incision was closed and cleaned with 10%
povidone. In order to replenish fluid loss during the
operation subcutaneous saline was applied at a rate
of 5% of body mass. The rats in the I/R + decorin
group were administered decorin (Sigma-Aldrich)
intraperitoneally at a dose of 0.1 mg/kg for 9 days
after reperfusion. In the sham group, their renal
pedicles were identified after dissection and the
procedure was ended without clamping.
After 9 days, all the rats in the 3 groups were
unilaterally nephrectomized under 100 mg/kg
ketamine anaesthesia. Nephrectomized kidneys
were divided into 2 pieces from the pelvis and kept
in 10% formaldehyde for pathological tests and kept
at –70°C for biochemical tests. Tissue samples 
were examined with Masson’s Trichrome stain  -
ing to evaluate collagen tissue; ImmunoCruz 
stain  ing to evaluate TGF-β1 values; and caspase 3
staining to evaluate apoptotic activity.
Lipid peroxidation (LPX) and superoxide
dismutase (SOD) enzyme levels were tested
biochemically. To detect SOD and LPX enzyme
activities in kidney tissue, 50 mM phosphate buffer
(pH 7.4) was prepared. SOD activity was measured
according to the method described by Fridovich [14].
This method employs xanthine and xanthine
oxidase to generate superoxide radicals that react
with p-iodonitrotetrazolium violet to form a red
formazan dye that was measured at 505 nm. A SOD
activity was expressed as U/g wet tissue. The
procedure described by Ohkawa et al. [15] was
followed to estimate the LPX. The principle depends
on the reaction between thiobarbituric acid with
malondialdehyde, a secondary product of LPX, at
pH 4. The reddish pink colour developed was
measured at 532 nm, which indicates the extent of
peroxidation. The extent of LPX is expressed as
nmol/g wet tissue. 
Tissue samples for histopathological tests were
fixed in 10% formalin. They were embedded in
paraffin blocks and sliced to 4 μm. Biopsy
preparations were stained with haematoxylin-eosin
(H/E) and Masson’s trichrome stain (to evaluate
collagen tissue) before examination by a specialist
pathologist under light microscopy. Each
preparation of nephrectomy materials was
examined in 20 different magnification areas for
cell counts. Kidney tissue sections were stained
immunohistochemically with polyclonal antibody of
TGF s1 (ImmunoCruz TM Staining System, 
sc-146K:TGF-s1(V) K-Santa Cruz Biotechnology) on
Poly-L-Lysine coated slides. To determine caspase
3 activity extracted kidneys were centrifuged and
supernatants collected. Protein extracts (50 μg)
were diluted in 1 ml of protease assay buffer.
Samples were analysed using a fluorimeter.
For the evaluation of all results, ANOVA, Tukey’s
b and Kruskal-Wallis tests were used. Values of 
p < 0.001 were considered significant. Results are
presented as mean ± SD.
Results
ImmunoCruz staining determined that the
number of TGF-β1 containing cells was significantly
different in the three groups. The numbers of cells
stained with TGF-β1 in a 20 magnification area in
sham, I/R and I/R + decorin groups were 47 ±25.39
(range: 8-90), 286 ±111.18 (range: 175-530) and
46.89 ±13.57 (range: 27-68) respectively (Table I,
Figures 1-2). TGF-β1 stained cells were lower in the
I/R + decorin group (p < 0.001).
To evaluate apoptotic activity levels, caspase
staining indicated a statistically significant diffe  -Arch Med Sci 2, April / 2011 213
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rence between the 3 groups in the case where all
the stained cells are counted. The number of
caspase stained cells was lower in the I/R + decorin
group. The results for sham, I/R and I/R + decorin
groups were 1251.56 ±232.40 (range: 811-1359),
2416.63 ±360.78 (range: 1969-3023) and 169.11
±73.15 (range: 66-253) (Table I, Figures 3-4).
Examination of Masson’s trichrome staining of
nephrectomy materials (to evaluate collagen tissue)
showed that the amount of collagen in interstitial
tissue was higher in the I/R group than in the I/R +
decorin group. This difference was not statistically
significant.
The levels of the enzyme lipid peroxidase, which
exists in the I/R mechanism, and the SOD enzyme,
which is produced to prevent this damage, were
biochemically assessed. Comparing superoxide
dismutase levels in sham, I/R and I/R + decorin
groups proved the last group to have the highest
value: 32.31 ±4.08 (range: 25-36.5), 47.52 ±3.76
(range: 42.79-53.07) and 57.45 ±3.48 (range: 52.76-
63.19) (unit/g wet tissue) respectively. There was
a statistically significant difference between the
three groups (p < 0.001) (Table I).
A statistically significant difference was observed
in evaluating the three groups for lipid peroxidation.
The enzyme levels for sham, I/R and I/R + decorin
groups were 30.78 ±4.56 (range: 24.96-37.12), 35.56
±2.34 (range: 32-38.4) and 32.14 ±4.32 (range: 26.84-
38.4) (nmol/g wet tissue) respectively (p < 0.001)
(Table I).
Sham (n = 9) I/R (n = 9) I/R + decorin (n = 16)
SOD [U/g wet tissue] 32.31 ±4.08 47.52 ±3.76 57.45 ±3.48
LPX [nmol/g wet tissue] 30.78 ±2.34 35.56 ±4.56 32.14 ±4.32
Caspase  1251.56 ±232.40 2416.63 ±360.78 169.11 ±73.15
TGF-β1  47.00 ±25.39 286.19 ±111.18 46.89 ±13.57
Table I. Results of three groups 
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Figure 2. In the decorin administered group, fewer
cortical renal tubular cells show cytoplasmic 
TGFβ-1 positivity compared to the control group
(TGFβ-1 ×400)
I/R – ischaemia-reperfusion, SOD – superoxide dismutase, LPX – lipid peroxidation, TGF – transforming growth factor 
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Figure 4. In the decorin administered group, fewer
cortical renal tubular cells show cytoplasmic caspase
positivity compared to the control group (Caspas
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Discussion
Decorin is a member of the small leucine-rich
proteoglycans (SLRPs) family. SLRPs interact with
various cytokines, including TGF-β, bone
morphogenic protein, Wnt-I-induced secreted
protein-I, von Willebrand factor, platelet-derived
growth factor and tumour necrosis factor-α [16, 17].
Decorin, biglycan, asporin, and fibromodulin bind
the profibrotic cytokine TGF-β [18, 19]. Besides
inhibition of TGF-β-mediated fibrosis, the binding
of decorin to TGF-β has significant biological
implications in regulating a number of cellular
processes, e.g. modulation of cell proliferation [20],
inhibition of repressive effects of TGF-β on macro  -
phages leading to their activation [21], and
suppression of TGF-β-dependent apoptosis in bone
marrow stromal cells [22]. 
Renal ischaemia and successive reperfusion
processes, the main reason for renal dysfunction,
are commonly seen in renal transplantation, surgical
revascularization of the renal artery, partial
nephrectomy and treatment of suprarenal aortic
aneurysm [23]. Renal ischaemia-reperfusion is
a complex process which includes many different
mechanisms such as renal vasoconstriction and
diffuse tubular and glomerular damage [24]. The
mechanism for defining ischaemia reperfusion
damage includes anoxia, the release of reactive
oxygen species (ROS) such as superoxide radicals
(O2
–), hydrogen peroxide (H2O2), hydroxyl radicals
(OH–) through reperfusion, neutrophil accumulation
and the release of additional ROS and lytic enzymes
[25, 26]. In many studies it has been shown that
ROS has a crucial role in ischaemia-reperfusion via
lipid peroxidation of cells [25-27]. By fatty acid
peroxidation the membrane structure and function
of mitochondrial lysosomes may change [25]. In our
study lipid peroxidation levels in the sham group
were statistically significant in comparison with the
I/R and I/R + decorin group. In the I/R + decorin
group this level was statistically higher than the
sham group but lower than the I/R group. 
A SOD is an antioxidant agent found in renal
cells. It is a natural protector against injury caused
by free radicals that are the end products of
ischaemia and reperfusion [25, 27]. In our study
SOD levels were compared in the three groups and
found to be statistically different. In the I/R group
its level was statistically higher than the sham
group. In the I/R + decorin group this level was
significantly higher. These data imply that the
amount of this protective agent produced in the
organ increased to prevent damage. In terms of the
mechanism describing the ischaemia and
reperfusion damage, this damage is reduced by
decorin secretion and the amount of protective
agent rises. There is no publication that determines
the relationship between lipid peroxidation, SOD
and decorin levels. Some articles relate increments
in the TGF-β1 level by superoxide via induction of
gene expression in cardiac fibroblasts [28]. In
another study the preventive effect of decorin on
adhesion and fibrosis via TGF-β1-dependent and
independent mechanisms, and the role of cytokines
on ischaemia reperfusion were investigated [29].
The effect of decorin on ischaemia-reperfusion is
conducted through unidentified mechanism
pathways. In previous studies, excessive production
of TGF-β1 was detected as the main reason for
tissue fibrosis after illness and tissue damage [30].
It was shown that TGF-β1 is an important cytokine
in scar formation and that its production increases
the tissue repair process. Additionally decorin has
some roles in biological functions such as matrix
formation [31, 32], altering the cell adhesion
strength and structure by use of fibronectin and
thrombospondin [32, 33] and controlling the activity
of TGF-β1 in tissue fibrosis [33-36]. Decorin can also
be used in renal parenchymal diseases as well as
pulmonary and vascular disorders to reduce tissue
fibrosis [10-13]. A previous study showed that renal
ischaemia and reperfusion significantly induced
tubular necrosis and inflammatory cell infiltration
on the first day, and tubular atrophy and interstitial
fibrosis by the eighth day [37]. Being exceptionally
different from the other literature this study is
based on this fact. This study evaluated the TGF-β1
level, the effect of externally administered decorin
on the TGF-β1 level, and the influence of this effect
on fibrosis and apoptotic changes. In another study
indium stained decorin was administered to rats
with a dose of 0.02-0.1 mg/kg and its metabolism
in the vascular system was observed. Seventy
percent of administered decorin accumulated in the
liver in the first 10 min. The residual amount was
detected in the kidney, spleen and urine. There was
no significant radioactive accumulation in heart,
lungs and muscle. Additionally it was found that as
the dose increases, its metabolism rate slows [38].
In our study, decorin was given at a dose of 
0.1 mg/kg – higher than the physiological limits.
Contrary to former articles, we did not observe
significant fibrotic changes after the assessment of
standard staining methods displaying collagen
tissue production and fibrosis. However, the
assessment of the results of immunohistochemical
staining methods displayed apoptotic changes
(caspase 3) and TGF-β1 levels (TGF-β1 ImmunoCruz
Staining System) showed a statistically significant
difference between the 3 groups.
Immunohistochemical staining for apoptotic
changes showed that the number of caspase-
stained cells was lower in the I/R + decorin group.
The TGF-β1 level was also lower in the I/R + decorin
group than in the I/R group. In light of this fact,
apoptotic activity and the TGF-β1 level, known toArch Med Sci 2, April / 2011 215
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be the initiator of fibrotic activity, were lower in the
I/R + decorin group. In a similar study, apoptosis in
tubular epithelial cells and the rise in TGF-β1 m-RNA
levels were doubled in rats which were subjected
to decorin abstinence and post-ureteral obstruction
[39]. However, in that study decorin was not
administered as a treatment option.
In conclusion, TGF-β1 can cause renal dys  -
function by means of interstitial and glomerular
fibrosis as a response to acute ischaemia. We found
that the TGF-β1 level – the so-called initiator of
fibrotic activity – and apoptotic activity were low in
the I/R + decorin group. Additional studies must be
performed to understand the role of decorin in
inhibition of TGF-β1 and for assessment of decorin’s
routine use in acute renal ischaemia.
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